The role of endoscopic ultrasonography in the management of cystic lesions of the pancreas by Chan, ACY & Liu, CL
Title The role of endoscopic ultrasonography in the management ofcystic lesions of the pancreas
Author(s) Chan, ACY; Liu, CL
Citation Hong Kong Medical Journal, 2003, v. 9 n. 6, p. 441-445
Issued Date 2003
URL http://hdl.handle.net/10722/45425
Rights Creative Commons: Attribution 3.0 Hong Kong License
Hong Kong Med J Vol 9 No 6 December 2003      441
REVIEW ARTICLE
Key words:
Endosonography;
Pancreatic neoplasms;
Pancreatic pseudocyst
 !
 !"#$%&
 !
 !"#
Hong Kong Med J 2003;9:441-5
The role of endoscopic ultrasonography
in the management of cystic lesions of
the pancreas
Objective. To review the role of endoscopic ultrasonography in the management
of cystic lesions of the pancreas.
Data sources. MEDLINE literature search (1998-2003).
Study selection. Key words for the literature search were ‘endoscopic
ultrasonography’, ‘pancreas’, ‘pseudocyst’, and ‘cystic tumor’.
Data extraction. All relevant studies were reviewed.
Data synthesis. In the management of cystic lesions of the pancreas, endoscopic
ultrasonography appears to be superior to percutaneous ultrasonography,
computed tomography, and endoscopic retrograde cholangiopancreatography,
because it can achieve detailed imaging of both the pancreatic parenchymal tissue
and the ductal anatomy simultaneously with a high-frequency ultrasound
examination at a close proximity. Endoscopic ultrasonography can differentiate
benign pseudocysts or benign cystic lesions from malignant neoplasms of the
pancreas; the distinction is crucial in the surgical treatment of the patients. The
diagnostic accuracy can be further enhanced with endoscopic ultrasonography–
guided fine-needle aspiration of the cystic fluid to detect tumour markers and
cytological examination. Endoscopic ultrasonography–guided aspiration with or
without endoscopic cystogastrostomy or cystoduodenostomy has become the
treatment of choice for patients with pancreatic pseudocysts. The procedure is
associated with decreased morbidity and mortality when compared with open
surgery.
Conclusion. Endoscopic ultrasonography appears to be a useful tool in the
management of cystic lesions of the pancreas.
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Introduction
Endoscopic ultrasonography is one of the most important areas of development
in gastrointestinal endoscopy. It is an invaluable tool in the diagnosis, staging,
and management of most upper and lower gastrointestinal disorders,1 such as
oesophagogastric tumours,2,3 oesophageal varices,4 Barrett’s oesophagus,5 rectal
cancer3,6,7 and other rectal diseases.8 Endoscopic ultrasonography is also very
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useful in the management of diseases of the lung9,10 and
thyroid,11 mediastinal tumours,12 and diseases of the
gastrointestinal tract. In this article, we review the role of
endoscopic ultrasonography in the management of cystic
lesions of the pancreas.
Approximately 90% of all cystic lesions of the pancreas
are benign pseudocysts, which are related to acute and
chronic pancreatitis, and trauma. The remaining 10% of
cases are cystic neoplasms.13,14 The conventional imaging
methods that are used to diagnose cystic tumours of the
pancreas are transabdominal ultrasonography, abdominal
computed tomography (CT) and endoscopic retrograde
cholangiopancreatography (ERCP). Computed tomography
is useful in demonstrating any involvement of parenchy-
mal tissue, whereas ERCP, despite its invasiveness, is more
effective in visualising the ductal anatomy.15,16 Endoscopic
ultrasonography appears to be superior to both CT and
ERCP, because it can achieve a detailed image of both
pancreatic parenchymal tissue and the ductal anatomy at
the same time.17
Endoscopic ultrasonography is a combination of two
investigation modalities—namely, endoscopic visualisation
and high-frequency ultrasonography.18,19 Two types of
endoscopic ultrasonography are commonly used:
mechanical radial echo-endoscopy, which provides 360Ο
images perpendicular to the longitudinal axis of the
endoscope, and curvilinear electronic array endoscopy,
which provides images sagittal to the longitudinal axis of
the endoscope. Both types of endoscopy can operate at
different frequencies, thereby allowing different depths of
penetration. The close proximity of the pancreas to the
stomach and duodenum is well within the range of endo-
scopic ultrasonography. Hence, the head, body, and tail
of the pancreas can be visualised clearly, and the
pancreatic duct can also be examined in detail.1,20,21
Pancreatic pseudocyst
Pancreatic pseudocysts may develop as a complication of
acute or chronic pancreatitis, trauma, or pancreatic duct
obstruction by tumour. Small pseudocysts usually do not
require intervention, and spontaneous resolution is
common. In contrast, spontaneous resolution occurs less
frequently in large pseudocysts, and the risk of develop-
ing a complication is high. It has been recommended
that any pseudocysts larger than 6 cm and persistent
for more than 6 weeks be drained.22-24 Management of
pancreatic pseudocysts consists of surgical drainage,
percutaneous drainage under the guidance of ultra-
sonography or CT, or endoscopic drainage. Although
surgical drainage has been the standard treatment, it is
associated with significant operative morbidity rate of 10%
and mortality rate of about 1%.24 In the past decade,
percutaneous and endoscopic drainage has become the
treatment of choice for pseudocysts and has gradually
replaced surgical drainage in most cases.25,26
Endoscopic ultrasonography plays both diagnostic
and therapeutic roles in the management of pancreatic
pseudocysts. During the examination, pseudocysts may
appear uniloculated or multilocated. The cyst wall and the
septa are usually thin and are made up of fibrous tissue.
Although a clinical history of pancreatitis may make the
diagnosis of simple pancreatic pseudocyst more likely, it
can be difficult to distinguish pancreatic pseudocysts from
cystic neoplasms by using endoscopic ultrasonography
alone.27 However, endoscopic ultrasonography–guided
aspiration and cystic fluid analysis can be very helpful
in achieving the diagnosis. Aspirates from pancreatic
pseudocysts usually yield fluid with a high level of amylase,
low levels of tumour markers, and inflammatory cells
(Table).14,28-32
Endoscopic ultrasonography–guided drainage has
become the treatment of choice for complicated pancreatic
pseudocysts; the method has a high success rate and causes
minimal morbidity and mortality.33 The most common route
of drainage is through either the stomach or the duodenum.
As a general rule for safe drainage, the maximum distance
between the pseudocyst and the gut lumen should be
less than 1 cm. Any greater distance increases the risk of
perforation during endoscopic drainage. In addition,
identification of the indentation in the gut wall created by
the bulk of the pseudocyst gives a rough guide to the
pseudocyst’s exact location in relation to the gut lumen.33
The presence of anechoic material inside the cystic cavity
indicates an ideal lesion for endoscopic ultrasonography–
guided drainage. On the other hand, substantial hyper-
echoic material indicates the presence of debris or necrotic
tissue, which in turn would prompt the endoscopist to
use endoprosthesis for optimal drainage. Endoscopic
ultrasonography can also detect any vascular structure in
the wall or in between the pseudocyst and the gut wall,
including varices and retroperitoneal vessels. Avoidance of
such structures on needle passage during drainage is crucial
in minimising the associated risk of haemorrhage.33
* CEA     carcinoembryonic antigen
Table. Fluid analysis of cystic lesions of the pancreas
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Serous cystadenoma
Using endoscopic ultrasonography, serous cystadenoma
(SCA) typically appears as multiple microcystic com-
partments with thin septations. Depending on the size of
the tumour, a large SCA can occasionally appear as a single
macrocystic lesion. Another morphological feature of SCA
is the presence of central calcifications in about 15% of all
cases. In addition, SCA can typically appear as an anechoic
lesion. In contrast, the presence of mixed hyperechoic
signals are likely to be associated with debris and are more
commonly found in mucinous cystadenomas (MCAs). The
fact that most cases of SCA are microcystic lesions has
rendered endoscopic ultrasonography–guided fine-needle
aspiration (FNA) less reliable, because it is difficult to pass
the needle into the small-size compartments. Acellularity in
the aspiration fluid can make up to 50% of all cases and
result in a diagnostic accuracy of only 25%.16,34 However,
the presence of glycogen-rich cells in the cyst aspirate is a
diagnostic feature of SCA.13
Mucinous cystadenoma and mucinous
cystadenocarcinoma
Mucinous cystadenoma is the most common primary
cystic tumour of the pancreas, accounting for about 45%
of all cases. There is a female preponderance and
middle-aged women are mostly affected. Mucinous
cystadenoma is recognised as a group of tumours with
heterogeneous pathological features, ranging from slow-
growing benign tumour to aggressive malignant
mucinous cystadenocarcinoma (MCAC). In more
than half of cases, histological examination of the
resected tumour reveals co-existing benign and
malignant epithelia. Hence, MCA is generally regarded
as potentially malignant, and surgical resection is
considered as first-line treatment.
The typical features of MCA under endoscopic
ultrasonography are macrocystic, single loculation, and
peripheral calcification. Sometimes, a large MCA could be
divided by thin septae that form multiple fluid-filled
compartments. The lining of the wall is relatively thin, and
the lesion is usually well demarcated from the pancreas.
Floatation of mucus within the cystic fluid is sometimes
visible.35 A large multiloculated lesion should warrant
surgical resection in view of the risk of malignant trans-
formation. Similarly, a single loculated lesion in the
absence of a clinical history of pancreatitis or pan-
creatic trauma should also be resected, owing to the
likelihood of a mucinous neoplasm. However, a diagnostic
challenge will arise when a multiloculated lesion is
found in a patient who has a history of pancreatitis
or pancreatic trauma. In this case, FNA with cystic
fluid analysis will increase the diagnostic accuracy of
endoscopic ultrasonography.
The combination of ultrasonography and CT is
inaccurate in the diagnosis of MCAC, and 40% to 60% of
cases can be misinterpreted as pseudocyst.35 This can be
explained by the limited spatial resolution of these
two imaging modalities and the pathological features of
MCAC. Typically, MCAC is a thick-walled macrocyst
with intracystic mural nodules or extracystic solid com-
ponents in small tumours. A dilated pancreatic duct is pres-
ent in about 80% of cases. Endoscopic ultrasonography
has a higher spatial resolution than ultrasonography and
CT, and so it can clearly delineate the internal architecture
of the pancreatic parenchyma precisely. Endoscopic
ultrasonography might also be more sensitive in detecting
cystic tumours of less than 2 cm in diameter.36  The overall
5-year survival rate for resected MCAC is more than 50%,
and curative resection can be achieved in 74% of patients.37
The prognosis of unresected MCAC is dismal and
comparable with unresected pancreatic adenocarcinoma.
Hence, an aggressive surgical approach may be justified
for radical resection of MCAC, even when there is local
spread to neighbouring structures.
Fig. (a) Picture of endoscopic ultrasonography showing a
multiloculated cyst (C) with echogenic material at the neck of
the pancreas, compatible with mucinous
cystadenocarcinoma. (b) Endoscopic ultrasonography–
guided aspiration with a 21-gauge needle (N) of the lesion
(C) yielding thick clear fluid; biochemical analyses of the
aspirate showed a low amylase level (<70 U/L) and a very
high carcinoembryonic antigen level (>10 000 ng/mL)
(b)
(a)
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Fine-needle aspiration and cystic fluid analysis
It has been reported that FNA and cystic fluid analysis
significantly increase the accuracy of the diagnosis of
pancreatic cystic tumour (Fig).30,38 Cystic fluid analysis with
various tumour markers and enzymes have been extensively
studied (Table). Nevertheless, it is important to appreciate
that no single marker is specific enough to differentiate
between benign lesions and malignant tumours. Cystic fluid
in mucinous cystic tumour is generally more viscous than
SCA and pancreatic pseudocysts. It may be related to the
high protein concentration of the cystic fluid, although
differences in total protein concentration among various
cystic lesions are yet to be determined.30,38 The level of
amylase is significantly higher in pancreatic pseudocysts
than in cystic neoplasms of the pancreas, because pseudo-
cysts frequently communicate with the pancreatic
ductal system. A high level of amylase itself is the single
most important determinant factor in establishing the
diagnosis of pseudocysts.30,39
Carcinoembryonic antigen (CEA) is a good tumour
marker to differentiate mucinous lesion from non-mucinous
neoplasms: the former is associated with a high CEA level.
The presence of CEA is usually normal in pseudocysts and
SCA. A CEA level of more than 400 ng/mL (>400 µg/L) is
potentially predictive of malignancy.30,39 CA-72.4 has been
increasingly recognised as one of the best tumour markers
in differentiating MCAC from benign pseudocysts. Although
studies with other tumour markers such as CA-19.9 and
CA-15.3 have also shown promising results, the sensitivities
and specificities of measuring levels of these markers appear
to be inferior to those of measuring CA-72.4 in detecting
MCAC. Sperti et al40 reported a sensitivity of 87.5% and a
specificity of 94.0% of CA-72.4 in the detection of mucinous
tumours. Expression of CA-72.4 may occur during the malig-
nant transformation of a benign mucinous cystic tumour.41
Cyst-fluid cytology is useful in diagnosing MCA and
MCAC through the identification of mucin epithelial
cells and malignant cells, respectively. When positive cells
are present, the specificity of fluid cytology is close to
100%. However, cyst-fluid cytology is often negative, and
inadequate cystic fluid sampling also jeopardises the
reliability of this technique. Centeno et al32 reported a
prospective evaluation of FNA on 28 radiographically
identified cysts. The overall accuracy of cyst-fluid cytology
was 40% for mucinous cysts and 67% for malignant cystic
tumours.
The technique of FNA of cystic tumours of the pancreas
is similar to FNA of pancreatic solid masses.42 However, in
view of the fluid component of the tumour, multiple needle
punctures would certainly increase the risk of perforation
and cystic rupture. Hence, a single-needle pass technique is
usually adopted. Although there is a theoretic risk of needle
tract tumour seeding during FNA for suspected malignant
cystic lesions, such a complication has yet to be reported.
Conclusion
Endoscopic ultrasonography is a useful diagnostic tool in
the assessment of cystic lesions of the pancreas. It can help
to avoid characterising a mucinous cyst as a benign serous
cyst and erroneously opting for simple observation instead
of choosing early surgical resection for cure. Endoscopic
ultrasonography–guided FNA with cystic fluid analysis can
further enhance the diagnostic accuracy. Endoscopic
ultrasonography–guided drainage is the treatment of choice
in most patients with pancreatic pseudocysts.
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